Members Sign In
Members Sign InAll | Clinical Notices | General Notices | Vacancies
Welcome to Issue 186 of Diabetes and Obesity Research Review.
In this issue, our neighbours across the Tasman have provided us with some data on how insulin utilisation and costs have changed over the last two decades in light of increased SGLT-2 inhibitor and GLP-1 agonist use.
As usual we have attached the PDF, and you can also view the issue online.
Some of the other highlights include:
I hope you enjoy the papers selected for this issue and find them beneficial to you and your patients. Your feedback and suggestions are always welcome, please continue to send them in.
Kind regards,
Professor Jeremy Krebs
jeremykrebs@researchreview.co.nz
Diabetes Clinical Nurse Specialist role
Click HERE to view advertisement for role
Welcome to Issue 186 of Diabetes and Obesity Research Review.
In this issue, our neighbours across the Tasman have provided us with some data on how insulin utilisation and costs have changed over the last two decades in light of increased SGLT-2 inhibitor and GLP-1 agonist use.
As usual we have attached the PDF, and you can also view the issue online.
Some of the other highlights include:
I hope you enjoy the papers selected for this issue and find them beneficial to you and your patients. Your feedback and suggestions are always welcome, please continue to send them in.
Kind regards,
Professor Jeremy Krebs
jeremykrebs@researchreview.co.nz
Kia ora koutou
You may have seen advertised that NZMS are holding Funded Product Expos around the country.
Their communication to me was:
'We have invited regional community stakeholders; Pharmac, PHOs, GP Associations, Pharmacy Groups, Pharmacy Wholesalers, Patient Advocacy Groups, GPs, Patients etc. Our Objective is to provide a forum where the Type One Community and its network can learn more about the funded products, the funding process, network and ask any questions. There will no doubt be clinical questions from Pharmacy and GP's that the NZSSD are better placed to address. Hopefully, there will be NZSSD Members able to attend.'
We have been very clear that NZSSD will not advocate for one product over another, however if you feel that attending these expos will be helpful for our people with T1DM you would be welcome to register and attend. You may wish to pass the information on to your patients as well.
The dates and locations are:
CHRISTCHURCH
5th November 2024
6.30pm-9.30pm
Venue: Camelot Room, DoubleTree by Hilton Chateau on the Park Christchurch
189 Deans Avenue, Riccarton, Christchurch, 8011, New Zealand
Register to attend in Christchurch
AUCKLAND
21st November 2024
6.30pm-9.30pm
Venue: Rimu 2 & 3 rooms, Novotel
Auckland Ellerslie
72-112 Greenlane East, Ellerslie Auckland, New Zealand
Register to attend in Auckland
WELLINGTON
4 December 2024
6.30pm - 9.30pm
Venue: QT Wellington 90 Cable Street Te Aro Wellington, 6011
Ngā mihi
Rosemary
Dr Rosemary Hall
Endocrinologist,
President New Zealand Society for the Study of Diabetes
president@nzssd.org.nz
Secretariat: Secretary@nzssd.org.nz
Click HERE to view this issue online
We know that this decision will also bring some anxiety for
our already stretched health system and workforce. NZSSD will provide as much
clinical and practical support as we can to enable the process to be as
streamlined and equitable as possible. We will keep you informed of education
opportunities and guidelines and welcome widespread discussion and resource
sharing.
I have attached our media release.
Pharmac's information page has details of the revised special authority criteria and processes around transitioning people from Medtronic systems.
|
Ngā mihi
Rosemary
Dr Rosemary HallEndocrinologist
President New Zealand Society for the Study of Diabetes
president@nzssd.org.nz
secretary@nzssd.org.nz
NZSSD website: www.nzssd.org
Please see the attached notice.
We suggest transferring people over to a new insulin well in advance of 30 September, to avoid any supply issues
See the attached flyer or click HERE to view online.
Kia ora,
A jointly funded summer student from 18/12 ago has now got her research published. The reference is: Barnhill, K., Chia, L., Heenan, H., Power, J., Frampton, C., & Lunt, H. (2024). Clinical audit describing equity of access and clinical features of patients with and without diabetes accessing a hospital dental clearance pathway. New Zealand Dental Journal, 120(2), 75-81.
Please find enclosed a copy of her article.
The Dietitians SIG are carrying out a review of the practice of precise carbohydrate counting (grams or flexible dosing) at diagnosis around the country. Can you please follow the link to the survey monkey, which takes about 5-7 minutes to complete.
Many thanks.
Deadline for Abstract Submission & Travel Grant Application: Aug 1(Thu), 2024 *KST
Deadline for Early Registration: Sep 2(Mon), 2024 *KST
Conference website: icdm.or.kr
Korean Diabetes Association website: diabetes.or.kr